Eric B Loucks1, Stephen E Gilman2, Willoughby B Britton3, Roee Gutman4, Charles B Eaton5, Stephen L Buka6. 1. Brown University School of Public Health, Department of Epidemiology, Providence, RI, USA. eric.loucks@brown.edu. 2. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA. 3. Brown University Warren Alpert Medical School, Department of Psychiatry and Human Behavior, Providence, RI, USA. 4. Brown University School of Public Health, Department of Biostatistics, Providence, RI, USA. 5. Brown University Warren Alpert Medical School, Department of Family Medicine, Providence, RI, USA. 6. Brown University School of Public Health, Department of Epidemiology, Providence, RI, USA.
Abstract
OBJECTIVE: To evaluate whether dispositional mindfulness is associated with glucose regulation and type 2 diabetes. METHODS: Study participants (N = 399) were from the New England Family Study, a prospective birth cohort, with median age 47 years. Dispositional mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS). Type 2 diabetes and "normal plasma glucose" were defined using American Diabetes Association criteria. RESULTS: Multivariable-adjusted regression analyses demonstrated that participants with high versus low MAAS scores were significantly more likely to have normal plasma glucose levels (prevalence ratio = 1.35 (95% confidence interval (CI): 1.08,1.87)), and were not significantly associated with type 2 diabetes (prevalence ratio = 0.83, 95% CI: 0.38,1.79), adjusted for age, sex, race/ethnicity, family history of diabetes and childhood socioeconomic status. Mediation analyses provided evidence of mediation via obesity and sense of control, where indirect effects were prevalence ratios (95% CI) of 1.03 (1.00,1.10) and 1.08 (1.00,1.21), respectively. CONCLUSIONS: Dispositional mindfulness may be associated with better glucose regulation, in part because of a lower likelihood of obesity and greater sense of control among participants with higher levels of mindfulness. These findings need to be replicated by prospective studies to establish causality and to evaluate potential implications for mindfulness-based interventions to reduce risk of type 2 diabetes.
OBJECTIVE: To evaluate whether dispositional mindfulness is associated with glucose regulation and type 2 diabetes. METHODS: Study participants (N = 399) were from the New England Family Study, a prospective birth cohort, with median age 47 years. Dispositional mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS). Type 2 diabetes and "normal plasma glucose" were defined using American Diabetes Association criteria. RESULTS: Multivariable-adjusted regression analyses demonstrated that participants with high versus low MAAS scores were significantly more likely to have normal plasma glucose levels (prevalence ratio = 1.35 (95% confidence interval (CI): 1.08,1.87)), and were not significantly associated with type 2 diabetes (prevalence ratio = 0.83, 95% CI: 0.38,1.79), adjusted for age, sex, race/ethnicity, family history of diabetes and childhood socioeconomic status. Mediation analyses provided evidence of mediation via obesity and sense of control, where indirect effects were prevalence ratios (95% CI) of 1.03 (1.00,1.10) and 1.08 (1.00,1.21), respectively. CONCLUSIONS: Dispositional mindfulness may be associated with better glucose regulation, in part because of a lower likelihood of obesity and greater sense of control among participants with higher levels of mindfulness. These findings need to be replicated by prospective studies to establish causality and to evaluate potential implications for mindfulness-based interventions to reduce risk of type 2 diabetes.
Authors: Judson A Brewer; Sarah Mallik; Theresa A Babuscio; Charla Nich; Hayley E Johnson; Cameron M Deleone; Candace A Minnix-Cotton; Shannon A Byrne; Hedy Kober; Andrea J Weinstein; Kathleen M Carroll; Bruce J Rounsaville Journal: Drug Alcohol Depend Date: 2011-07-01 Impact factor: 4.492
Authors: Eric B Loucks; Willoughby B Britton; Chanelle J Howe; Roee Gutman; Stephen E Gilman; Judson Brewer; Charles B Eaton; Stephen L Buka Journal: Int J Behav Med Date: 2016-04
Authors: Jenny van Son; Ivan Nyklíček; Victor J Pop; Marion C Blonk; Ronald J Erdtsieck; François Pouwer Journal: J Psychosom Res Date: 2014-03-31 Impact factor: 3.006
Authors: Emma L M Clark; Lauren D Gulley; Mark A Prince; Milena Casamassima; Natalia Sanchez; Virginia Jimenez; Sarah A Johnson; Reagan L Miller; Isabella Conte; Jill L Kaar; Stacey L Simon; Christopher Melby; Rachel G Lucas-Thompson; Lauren B Shomaker Journal: J Behav Med Date: 2021-04-21
Authors: Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Roger Brown; Aleksandra E Zgierska; Shari Barlow; Supriya Hayer; Jodi H Barnet; Elisa R Torres; Christopher L Coe Journal: PLoS One Date: 2018-06-22 Impact factor: 3.240
Authors: Zev Schuman-Olivier; Marcelo Trombka; David A Lovas; Judson A Brewer; David R Vago; Richa Gawande; Julie P Dunne; Sara W Lazar; Eric B Loucks; Carl Fulwiler Journal: Harv Rev Psychiatry Date: 2020 Nov/Dec Impact factor: 3.732